is invokana a glp-1 Medication Options for Type 2 Diabetes GLP-1 Agonists vs. SGLT2 Inhibitors:
Description
speaker fees (Teva)
Saxenda has not been studied in patients taking insulin
Call urgently for severe abdominal pain, especially with persistent vomiting
This pattern is not harmful and reflects normal physiological adaptation
Two years ago, one of these drugs, semaglutide, also was approved as an obesity treatment in the U.S., sparking an explosion in public interest
